Real-time enrollment status for this astrocytoma, idh-mutant, grade 2 clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 7:51 AM UTC
| NCT Number | NCT06860594 |
| Recruiting Status | Recruiting |
| Condition | Astrocytoma, IDH-Mutant, Grade 2 |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 43 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 26, 2026 (Yesterday) |
As of August 27, 2026: Clinical trial NCT06860594 is currently recruiting participants. This phase1 study for astrocytoma, idh-mutant, grade 2 is actively seeking new participants at 43 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06860594 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06860594 was last updated Yesterday (August 26, 2026). HelloStudys verifies this status automatically.